(Lauren Sciences LLC) Lauren Sciences LLC, the private New York biotechnology company developing transformative V-Smart® Nanomedicines for brain diseases, today announced it was awarded an AU$1 million translational grant from FightMND. The FightMND grant will advance Lauren Sciences development of LAUR-301, its novel V-Smart® Nanomedicine for ALS (amyotrophic lateral sclerosis), also known as Lou Gehrig's disease, or motor neuron disease (MND).
from EurekAlert! - Social and Behavioral Science https://ift.tt/2VcigI3
No comments:
Post a Comment